Home » Topics » BioWorld Science

BioWorld Science
RSS

Karo Pharma resolves rights issue regarding acquisition of product portfolio from LEO Pharma

April 6, 2018

Tie1 is a biomarker of survival in patients with metastatic breast cancer

April 6, 2018

MCM7 found as a useful marker for intestinal NET grading

April 6, 2018

AmnioStem cells show superior immune modulatory ability compared to other stem cell types

April 6, 2018

Terns Pharmaceuticals acquires three therapeutic candidates for the treatment of NASH from Lilly

April 6, 2018

ST-002 is granted FDA orphan drug designation

April 6, 2018

Samsung Bioepis initiates phase III trial of proposed ranibizumab biosimilar, SB-11

April 6, 2018

Patient enrollment ongoing in phase I trial of HA-1 T TCR T-cell Immunotherapy

April 6, 2018

Acrizanib shows efficacy as topical ocular therapy in models of choroidal neovascularization

April 6, 2018

IGF Oncology studies 765-IGF-MTX in MDS, CMML and oligoblastic AML

April 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...